An unconventional role for cytoplasmic disulfide bonds in vaccinia virus proteins

Journal of Cell Biology

Volumn 144, Issue 2, 1999, Pages 267-279

  Locker, Jacomine Krijnse ^a   Griffiths, Gareth ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

Disulfide bonding; Poxviridae; Reducing agents; Vaccinia virus; Viral assembly

Indexed keywords

DISULFIDE; DITHIOTHREITOL; GLUTATHIONE; GLUTATHIONE DISULFIDE; N ETHYLMALEIMIDE; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DISULFIDE BOND; HELA CELL; HUMAN; HUMAN CELL; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; VACCINIA VIRUS; VIRUS ASSEMBLY; VIRUS INFECTION;

ANTIVIRAL AGENTS; CYSTEINE; CYTOPLASM; CYTOSOL; DIMERIZATION; DISULFIDES; DITHIOTHREITOL; ETHYLMALEIMIDE; HELA CELLS; HUMANS; KINETICS; SULFHYDRYL REAGENTS; TRITIUM; VACCINIA VIRUS; VIRAL CORE PROTEINS; VIRAL ENVELOPE PROTEINS;

ANIMALIA; POXVIRIDAE; VACCINIA; VACCINIA VIRUS;

EID: 0033601739     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.144.2.267     Document Type: Article

References (61)

1. Braakman, I., H. Hoover-Litty, K.R. Wagner, and A. Helenius. 1991. Folding of influenza hemagglutinin in the endoplasmic reticulum. J. Cell Biol. 114: 401-411.
2. Braakman, I., I. Helenius, and A. Helenius. 1992. Manipulating disulfide bond formation and protein folding in the endoplasmic reticulum. EMBO (Eur. Mol. Biol. Organ.) J. 11:1717-1722.
3. Bulleid, N.J., and R.B. Freedman. 1988. Defective co-translational formation of disulfide bonds in protein disulphide-isomerase-deficient microsomes. Nature. 335:649-651.
4. Chertov, O.Y., I.N. Telezhinskaya, E.V. Zaitseva, T.B. Golubeva, V.V. Zinov'ev, L.G. Ovechkina, L.B. Mazkova, and E.G. Malygin. 1991. Amino acid sequence determination of vaccinia virus immunodominant protein p35 and identification of the gene. Biomed. Sci. 2:151-154.
5. Creighton, T.E., D.A. Hillson, and R.B. Freedman. 1980. Catalysis by protein disulfide isomerase of the unfolding and refolding of proteins with disulphide bonds. J. Mol. Biol. 142:43-62.
6. Creighton, T.E. 1983. Pathways and energetics of protein disulfide formation. In Functions of Glutathione: Biochemical, Physiological, Toxilogical, and Clinical Aspects. A. Larsson et al., editors. Raven Press. New York. 205-213.
7. Creighton, T.E. 1995. Proteins, Structures and Molecular Properties. W.H. Freeman and Company. New York. 98-100.
8. Cudmore, S., R. Blasco, R. Vincentelli, M. Esteban, B. Sodeik, G. Griffiths, and J. Krijnse Locker. 1996. A vaccinia virus core protein, p39, is membrane associated. J. Virol. 70:6909-6921.
9. de Vries, A.A.F., M.J.B. Raamsman, H.A. van Dijk, M.C. Horzinek, and P.J.M. Rottier. 1995. The small envelope glycoprotein (Gs) of equine arteritis virus folds into three distinct monomers and a disulfide-linked dimer. J. Virol. 69: 3441-3448.
10. Doms, R.W., R.A. Lamb, J.K. Rose, and A. Helenius. 1993. Folding and assembly of viral membrane proteins. Virology. 193:545-562.
11. Earl, P.L., and B. Moss. 1991. Preparation of cell cultures and vaccinia virus stocks. Curr. Prot. Mol. Biol. 16:1-7.
12. Easterbrook, K.B. 1966. Controlled degradation of vaccinia virions in vitro: an electron microscope study. J. Ultrastruct. Res. 14:484-496.
13. Ericsson, M., S. Cudmore, S. Shuman, R.C. Condit, G. Griffiths, and J. Krijnse Locker. 1995. Characterization of ts 16, a temperature sensitive mutant of vaccinia virus. J. Virol. 69:7072-7086.
14. Essani, K., and S. Dales. 1979. Biogenesis of vaccinia: evidence for more than 100 polypeptides in the virion. Virology. 95:385-394.
15. Freedman, R.B. 1995. The formation of protein disulfide bonds. Curr. Opin. Struct. Biol. 5:85-91.
16. Freedman, R.B., T.R. Hirst, and M.F. Tuite. 1994. Protein disulfide isomerase: building bridges in protein folding. Trends Biochem. Sci. 19:331-336.
17. Gaut, J.R., and L.M. Hendershot. 1993. The modification and assembly of proteins in the endoplasmic reticulum. Curr. Opin. Cell Biol. 5:589-595.
18. Gvakharia, B.O., E.K. Koonin, and C.K. Mathews. 1996. Vaccinia virus G4L gene encodes a second glutaredoxin. Virology. 226:408-411.
19. Hammond, C., and A. Helenius. 1995. Quality control in the secretory pathway. Curr. Opin. Cell Biol. 7:523-529.
20. Helenius, A., T. Marquardt, and I. Braakman. 1992. The endoplasmic reticulum as a protein-folding compartment. Trends Cell Biol. 2:227-231.
21. Holmgren, A. 1989. Thioredoxin and glutaredoxin systems. J. Biol. Chem. 264: 13963-13966.
22. Holowczak, J.A., and W.K. Joklik. 1967. Studies of the structural proteins of virions and cores. Virology. 33:717-725.
23. Holowczak, J.A. 1972. Uncoating of poxviruses. I. Detection and characterization of subviral particles in the uncoating process. Virology. 50:216-232.
24. Hwang, C., A.J. Sinskey, and H.F. Lodish. 1992. Oxidized redox state of glutathione in the endoplasmic reticulum. Science. 257:1496-1502.
25. Ichihashi, Y., M. Oie, and T. Tsuruhara. 1984. Location of DNA-binding proteins and disulphide-linked proteins in vaccinia virus structural elements. J. Virol. 50:929-938.
26. Jensen, O.N., T. Houthaeve, A. Shevchenko, S. Cudmore, M. Mann, G. Griffiths, and J. Krijnse Locker. 1996. Identification of the major membrane and core proteins of vaccinia virus by two-dimensional electrophoresis. J. Virol. 70:7485-7497.
27. Joklik, W.K. 1964. The intracellular uncoating of poxvirus DNA. II The molecular basis of the uncoating process. J. Mol. Biol. 8:277-288.
28. Joklik, W.K. 1962. The purification of four strains of poxvirus. Virology. 18:9-18.
29. Kates, J., and J. Beeson. 1970. Ribonucleic acid synthesis in vaccinia virus. I. The mechanism of synthesis and release of RNA in vaccinia cores. J. Mol. Biol. 50:1-18.
30. Katz, E., and B. Moss. 1970. Formation of a vaccinia virus structural polypeptide from a high molecular weight precursor: inhibition of rifampicin. Proc. Natl. Acad. Sci. USA. 66:677-684.
31. Katz, E., and B. Moss. 1970. Vaccinia virus structural polypeptide derived from a high molecular weight precursor: formation and integration into virus particles. J. Virol. 6:717-726.
32. Krijnse Locker, J., J.K. Rose, M.C. Horzinek, and P.J.M. Rottier. 1992. Membrane assembly of the triple-spanning coronavirus M protein. Individual transmembrane domains show preferred orientation. J. Biol. Chem. 267: 21911-21918.
33. Krijnse Locker, J., G. Griffiths, M.C. Horzinek, and P.J.M. Rottier. 1992. O-glycosylation of the coronavirus M protein. Differential localization of sialyl-transferases in N- and O-glycosylation. J. Biol. Chem. 267:14094-14101.
34. Krijnse Locker, J., S. Schleich, D. Rodriguez, B. Goud, E.J. Snijder, and G. Griffiths. 1996. The role of a 21-kDa viral membrane protein in the assembly of vaccinia virus from the intermediate compartment. J. Biol. Chem. 271: 14950-14958.
35. Kutay, U., E. Hartmann, and T.A. Rapoport. 1993. A class of membrane proteins with a C-terminal anchor. Trends Biochem. Sci. 3:72-75.
36. LaMantia, M.L., and W.J. Lennarz. 1993. The essential function of yeast protein disulfide isomerase does not reside in its isomerase activity. Cell. 74: 899-908.
37. Lodish, H.F., and N. Kong. 1993. The secretory pathway is normal in dithiothreitol-treated cells, but disulfide-bonded proteins are reduced and reversibly retained in the endoplasmic reticulum. J. Biol. Chem. 268:20598-20605.
38. Maa, J.-S., J.F. Rodriguez, and M. Esteban. 1990. Structural and functional characterization of a cell surface binding protein of vaccinia virus. J. Biol. Chem. 265:1569-1577.
39. Maa, J.-S., and M. Esteban. 1987. Structural and functional studies of a 39,000-Mr immunodominant protein of vaccinia virus. J. Virol. 61:3910-3919.
40. Moss, B. 1990. Poxviridae and their replication. In Fields Virology, B.N. Fields, D.M. Knipe, R.M. Chanock, M.S. Hirsch, J.L. Melnick, T.P. Monath, and B. Roizman, editors. Raven Press. New York. 2079-2111.
41. Moss, B., and E.N. Rosenblum. 1973. Protein cleavage and poxvirus morphogenesis: tryptic peptide analysis of core precursors accumulated by blocking assembly with rifampicin. J. Mol. Biol. 81:267-269.
42. Munyon, W., E. Paoletti, and J.T. Grace. 1967. RNA polymerase activity in purified infectious vaccinia virus. Proc. Natl. Acad. Sci. USA. 58:2280-2287.
43. Niles, E.G., and J. Seto. 1988. Vaccinia virus gene D8 codes for a virion transmembrane protein. J. Virol. 62:3772-3778.
44. Oie, M., and Y. Ichihashi. 1981. Characterization of vaccinia polypeptides. Virology. 113:263-276.
45. Opstelten, D.-J., P. de Groote, M.C. Horzinek, H. Vennema, and P.J.M. Rottier. 1993. Disulfide bonds in folding and transport of mouse hepatitis coronavirus glycoproteins. J. Virol. 67:7394-7401.
46. Rajagopal, I., B.-Y. Ahn, B. Moss, and C.K. Mathews. 1995. Roles of vaccinia virus ribonucleotide reductase and glutaredoxin in DNA precursor biosynthesis. J. Biol. Chem. 270:27415-27418.
47. Rodriguez, D., J.R. Rodriguez, and M. Esteban. 1993. The vaccinia virus 14-kilo-dalton fusion protein forms a stable complex with the processed protein encoded by the vaccinia virus A17L. J. Virol. 67:3435-3440.
48. Rodriguez, D., M. Esteban, and J.R. Rodriguez. 1995. Vaccinia virus A17L gene product is essential for an early step in virion morphogenesis. J. Virol. 69:4640-4648.
49. Rodriguez, J.R., C. Risco, J.L. Carrascosa, M. Esteban, and D. Rodriguez. 1997. Characterization of early stages in vaccinia virus membrane biogenesis: implication of the 21kDa and a newly identified 15kDa envelope protein. J. Virol. 71:1821-1833.
50. Roos, N., M. Cyrklaff, S. Cudmore, R. Blasco, J. Krijnse Locker, and G. Griffiths. 1996. A novel immunogold cryoelectron microscopic approach to investigate the structure of the intracellular and extracellular forms of vaccinia virus. EMBO (Eur. Mol. Biol. Organ.) J. 15:2343-2355.
51. Salmons, T., A. Kuhn, F. Wylic, S. Schleich, J.R. Rodriguez, D. Rodriguez, M. Esteban, G. Griffiths, and J. Krijnse Locker. 1997. Vaccinia virus membrane proteins p8 and p16 are co-translationally inserted into the rough ER and retained in the intermediate compartment. J. Virol. 71:7404-7420.
52. Sarov, I., and W.K. Joklik. 1972. Studies on the nature and location of capsid polypeptides of vaccinia virions. Virology. 50:579-592.
53. Sodeik, B., R.W. Doms, M. Ericsson, G. Hiller, C.E. Machamer, W. van't Hof, G. van Meer, B. Moss, and G. Griffiths. 1993. Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks. J. Cell Biol. 121:521-541.
54. Sodeik, B., S. Cudmore, M. Ericsson, M. Esteban, E.G. Niles, and G. Griffiths. 1995. Incorporation of p14 and p32 into the membrane of the intracellular mature virus. J. Virol. 69:3560-3574.
55. Takahashi, T., M. Oie, and Y. Ichihashi. 1994. N-terminal amino acid sequences of vaccinia virus structural proteins. Virology. 202:844-852.
56. Tatu, U., I. Braakman, and A. Helenius. 1993. Membrane glycoprotein folding, oligomerization and intracellular transport: effects of dithiothreitol in living cells. EMBO (Eur. Mol. Biol. Organ.) J. 12:2151-2157.
57. Van Slyke, J.K., S.S. Whitehead, E.M. Wilson, and D.E. Hruby. 1991. The multistep proteolytic maturation pathway utilized by vaccinia virus P4a protein: a degenerate conserved cleavage motif within core proteins. Virology. 183: 467-478.
58. Van Slyke, J.K., C.A. Franke, and D.E. Hruby. 1991. Proteolytic maturation of vaccinia virus core proteins: identification of a consensus motif at the N termini of the 4b and 25K virion proteins. J. Gen. Virol. 72:411-416.
59. Wittek, R., M. Haenggi, and G. Hiller. 1984. Mapping of a gene coding for a major late structural polypeptide on the vaccinia virus genome. J. Virol. 49: 371-378.
60. Wollfe, E.J., S. Vijaya, and B. Moss. 1995. A myristoylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies. Virology. 211:53-63.
61. Yang, W.P., S.Y. Kao, and W.R. Bauer. 1988. Biosynthesis and post-translational cleavage of vaccinia virus structural protein VP8. Virology. 167:585-590.